Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AstraZeneca PLC - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
AZN
New York
2834
www.astrazeneca.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AstraZeneca PLC
What the AstraZeneca-BMS rumors reveal about pharma megamergers
- Aug 6th, 2026 3:26 am
Sector Update: Healthcare Stocks Rise Late Afternoon
- Aug 5th, 2026 1:50 pm
Royalty Pharma Q2 Earnings Call Highlights
- Aug 5th, 2026 1:04 pm
Sector Update: Healthcare Stocks Advance Wednesday Afternoon
- Aug 5th, 2026 11:42 am
AstraZeneca-Bristol Myers’ $400B Merger Buzz Cools After Report Denies Talks – ‘There Never Was A Deal To Be Done’
- Aug 5th, 2026 10:17 am
AMGN Beats on Q2 Earnings, Lifts Outlook Despite Legacy Drug Pressure
- Aug 5th, 2026 9:55 am
European Stocks Close Mostly Higher in Wednesday Trading as Investors Monitor Middle East Developments
- Aug 5th, 2026 9:52 am
European Equities Traded in the US as American Depositary Receipts Edge Up in Wednesday Trading
- Aug 5th, 2026 9:12 am
AZN rebounds after report dismisses AstraZeneca-Bristol Myers merger speculation
- Aug 5th, 2026 8:01 am
Best Buy downgraded, Bristol Myers upgraded: Wall Street's top analyst calls
- Aug 5th, 2026 7:40 am
AstraZeneca and Bristol Myers Squibb merger talks denied
- Aug 5th, 2026 7:11 am
AZN spikes 6% after report it denies AstraZeneca-BMS merger talks
- Aug 5th, 2026 7:00 am
Royalty Pharma reports second quarter 2026 results
- Aug 5th, 2026 5:00 am
Elon Musk Has Lost the Midas Touch as AI Spending Booms
- Aug 5th, 2026 4:49 am
SOPHiA GENETICS partners with AstraZeneca for oncology diagnostics
- Aug 5th, 2026 3:45 am
AstraZeneca-BMY megadeal talk sparks huge market rift
- Aug 4th, 2026 12:47 pm
AstraZeneca Faces Fresh Pressure As $400B Bristol Myers Deal Talks Reportedly Persist
- Aug 4th, 2026 12:45 pm
SOPHiA GENETICS Q2 Earnings Call Highlights
- Aug 4th, 2026 12:04 pm
MRK Q2 Earnings & Sales Beat Estimates, '26 Sales View Raised
- Aug 4th, 2026 11:45 am
SOPH Stock Heads For Best Day In Over 8 Months – What’s Driving Today’s Super Rally?
- Aug 4th, 2026 9:23 am
Scroll